乳酸代谢异常与糖尿病肾病白蛋白尿及肾损伤相关
研究在糖尿病肾病小鼠模型中发现肾脏乳酸水平升高和能量代谢受损,ARB治疗可减少白蛋白尿并纠正代谢异常。单细胞测序显示近端小管LdhA上调,白蛋白尿与乳酸在鼠和东南亚2型糖尿病伴肾功能受损患者中显著相关,尿乳酸可预测血清肌酐翻倍或肾衰竭。
要点
- 糖尿病肾病小鼠肾脏乳酸升高、ATP降低,ARB治疗使乳酸趋于正常并增加ATP。
- 近端小管LdhA特异性上调,伴氧化应激通路增强。
- 尿乳酸可预测糖尿病患者血清肌酐翻倍或肾衰竭,与肾小管损伤标志物相关。
核心结论
- 肾脏代谢紊乱导致乳酸生成增加可能参与糖尿病肾病发病,尿乳酸水平可能作为肾病进展风险的生物标志物。
研究设计与样本
- 研究在模拟人类糖尿病肾病的DN小鼠模型中进行靶向代谢组学分析,并在东南亚2型糖尿病伴肾功能受损患者队列中验证。
主要发现
- DN小鼠肾脏乳酸水平升高、能量代谢受损,ARB治疗减少白蛋白尿、减轻肾脏病理并纠正多种代谢异常,使乳酸趋于正常并增加肾脏ATP含量。
- DN小鼠肾脏中LdhA和LdhB两种乳酸脱氢酶亚型表达显著增加,ARB治疗显著降低其表达;单细胞测序显示近端小管LdhA特异性上调,伴氧化应激通路表达增强。
- 小鼠和东南亚2型糖尿病伴肾功能受损患者中,白蛋白尿与乳酸显著相关;在糖尿病患者中该关联独立于ARB和ACEI使用。
- 尿乳酸水平预测血清肌酐翻倍或肾衰竭的临床结局,且尿乳酸水平与肾小管损伤和上皮应激生物标志物显著相关。
临床怎么用
- 尿乳酸水平可能作为糖尿病肾病进展风险的潜在生物标志物。
- ARB治疗可减少DN小鼠白蛋白尿、减轻肾脏病理并纠正代谢异常。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diabetic nephropathy (DN) is characterized by abnormal kidney energy metabolism, but its causes and contributions to DN pathogenesis are not clear. To examine this issue, we carried out targeted metabolomics profiling in a mouse model of DN that develops kidney disease resembling the human disorder. We found a distinct profile of increased lactate levels and impaired energy metabolism in kidneys of mice with DN, and treatment with an angiotensin-receptor blocker (ARB) reduced albuminuria, attenuated kidney pathology and corrected many metabolic abnormalities, restoring levels of lactate toward normal while increasing kidney ATP content. We also found enhanced expression of lactate dehydrogenase isoforms in DN. Expression of both the LdhA and LdhB isoforms were significantly increased in kidneys of mice, and treatment with ARB significantly reduced their expression. Single-cell sequencing studies showed specific up-regulation of LdhA in the proximal tubule, along with enhanced expression of oxidative stress pathways. There was a significant correlation between albuminuria and lactate in mice, and also in a Southeast Asian patient cohort consisting of individuals with type 2 diabetes and impaired kidney function. In the individuals with diabetes, this association was independent of ARB and angiotensin-converting enzyme inhibitor use. Furthermore, urinary lactate levels predicted the clinical outcomes of doubling of serum creatinine or development of kidney failure, and there was a significant correlation between urinary lactate levels and biomarkers of tubular injury and epithelial stress. Thus, we suggest that kidney metabolic disruptions leading to enhanced generation of lactate contribute to the pathogenesis of DN and increased urinary lactate levels may be a potential biomarker for risk of kidney disease progression.
引用
- Azushima K, Kovalik JP, Yamaji T, et al. Abnormal lactate metabolism is linked to albuminuria and kidney injury in diabetic nephropathy. Kidney Int. 2023. PMID: 37843477. doi:10.1016/j.kint.2023.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。